Falipamil

This classification denotes a calcium channel blocker with the molecular formula C24H32N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N6A93ZMN7U, chemically known as 2-(3-((3,4-dimethoxyphenetyl)methylamino)propyl)-5,6-dimethoxyphthalimidine but generally known as falipamil, which bears US NIH Compound Identifier 71222. European Medicines Agency schedules Falipamil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07500MIG. The term FALIPAMIL is an International Non-Proprietary Name. FALIPAMIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule falipamil under HS 29337900 and SITC 51561. As of Q4 2014, FALIPAMIL remains the US FDA Preferred Term for this commodity. Falipamil bears US NLM identifiers UMLS ID C0117251 and NCI Concept Code C65614. SMILES: O=C1N(CCCN(CCc2cc(OC)c(OC)cc2)C)Cc2c1cc(OC)c(OC)c2.